Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Alfred Mann Foundation (AMF) is a non-profit medical research organization dedicated to developing innovative medical technologies that address significant unmet medical needs. Founded in 1985 by entrepreneur Alfred E. Mann, the foundation focuses on bionics, neuromodulation, and implantable devices. AMF operates as a technology incubator, taking high-risk concepts through research, development, and clinical trials before spinning them off into independent commercial entities. Notable successes originating from the foundation include the cochlear implant, the rechargeable pacemaker, and advanced insulin pumps. The foundation's current work includes the Implantable Myoelectric Sensor (IMES) system for intuitive control of prosthetic limbs. By bridging the gap between academic research and commercialization, AMF ensures that breakthrough medical discoveries reach the patients who need them most.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alfred E. Mann Foundation.